Doctors’ group urges American Academy of Pediatricians to rethink minor transgender treatments

Yet the group affirmed it was “encouraged that the AAP is open to reevaluating its position” on those procedures. 

“There is a lack of any significant clinical evidence and a lack of long-term positive outcomes for children treated with puberty-blocking drugs, sex hormones, and transgender interventions,” ACPeds said. 

“Additionally, it is a known fact that gender dysphoria resolves in most minors who are allowed to go through puberty,” the statement continued. “We reaffirm our position that these interventions are scientifically unproven and amount to child abuse.” 

ACPeds in its statement urged the AAP to “take into account the mounting scientific evidence against transgender interventions on minors, which has led some countries, including the U.K., Finland, and Sweden, to pull back their support for such interventions.”

“There is no scientifically robust evidence to support transgender interventions on minors,” the statement concluded. 

In the press release the group offered links to ACPeds literature arguing that “transgender treatments harm children” and that teenage brains are still “under construction” and that consequently the “decision-making processes during adolescence are immature.”

No Byline Policy

Editorial Guidelines

Corrections Policy

Source